NeoGenomics, Inc (NASDAQ:NEO) Q3 2023 Earnings Conference Call November 6, 2023 4:30 AM ET
Company Participants
Kendra Sweeney - VP, IR
Chris Smith - CEO
Jeff Sherman - CFO
Vishal Sikri - President, Advanced Diagnostics
Warren Stone - President, Clinical Services
Conference Call Participants
Vidyun Bais - BTIG
Andrew Brackman - William Blair
Alex Nowak - Craig-Hallum Capital Group
David Westenberg - Piper Sandler
Madison Pasterchick - Morgan Stanley
Joseph Stringer - Needham & Company
Tom Stevens - TD Cowen
Prashant Kota - Goldman Sachs
Jacob Krahenbuhl - Stephens
Puneet Souda - Leerink Partners
Operator
Greetings. Welcome to the NeoGenomics Third Quarter 2023 Earnings Call -- Third Quarter 2023 Financial Results Conference Call and Webcast. At this time, all participants are in a listen-only mode. Please note this call is being recorded, and an audio replay will be available on the company's website.
Kendra Sweeney, Vice President of Investor Relations, you may begin your conference.
Kendra Sweeney
Thank you, John. Good afternoon, everyone, and welcome to the NeoGenomics third quarter financial results call. With me today to discuss the results are Chris Smith, Chief Executive Officer, and Jeff Sherman, Chief Financial Officer. Additional members of the management team are available for Q&A including Vishal Sikri, President of Advanced Diagnostics; Warren Stone, President of Clinical Services; and Melody Harris, President of Enterprise Operations. This call is being simultaneously webcast. We will be referring to a slide presentation that has been posted to the Investors tab on our website at ir.neogenomics.com.
Starting on Slide 2, during this call, we'll be making forward-looking statements regarding our anticipated future performance. We caution you that such statements reflect our best judgment based on factors currently known to us, and that actual events, or results could differ materially. Please refer to our most recent forms 10-K, 10-Q, and 8-K we filed with the SEC, to identify important risks and other factors that may cause our actual results to differ materially from the forward-looking statements.
The forward-looking statements made during this call speak only as of the original date of the call, and we undertake no obligation to update or revise any of these statements. During this call, in order to provide greater transparency regarding our operating performance, we refer to certain non-GAAP financial measures that involve adjustments to GAAP results.
The non-GAAP financial measures presented should not be considered an alternative to the financial measures required by GAAP, should not be considered measures of liquidity, and are unlikely to be comparable to non-GAAP financial measures provided by other company. Any non-GAAP financial measures referenced on this call are reconciled to the most directly comparable GAAP financial measure in a table available in the press release we issued this afternoon.